S198: EFFICACY AND SAFETY OF BELANTAMAB MAFODOTIN MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK

Detalles Bibliográficos
Autores principales: Kastritis, Efstathios, Palladini, Giovanni, Dimopoulos, Meletios A., Jaccard, Arnaud, Merlini, Giampaolo, Theodorakakou, Foteini, Fotiou, Despina, Minnema Minnema, Monique C., Wechalekar, Ashutosh, Papachristou, Elena, Manousou, Kyriaki, Sonneveld, Pieter, Schönland, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428327/
http://dx.doi.org/10.1097/01.HS9.0000967704.23014.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428327/
http://dx.doi.org/10.1097/01.HS9.0000967704.23014.16

Ejemplares similares